Self-assembled cyanidin-3-O-glucoside nanoparticles alleviate inflammation and ferroptosis induced by PRRSV infection

Xiaohan Chen, Yipeng Pang, Fructueux Modeste Amona, Zilu Liu, Fang Wang, Liang Yuan, Jiachen Yang, W. Zhang, Xingtang FangJournal of Virology 2025 · DOI

TL;DR

This study introduces novel self-assembled cyanidin-3-O-glucoside-chitosan-selenium nanoparticles (C3G-Cs-SeNPs) that effectively combat Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection. These nanoparticles not only inhibit viral replication but also mitigate inflammation and ferroptosis by modulating the SIRT1/Nrf2/HO-1 pathway, offering a promising new therapeutic strategy for this economically devastating swine disease.

What Problem Does This Paper Address?

Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is a major threat to the global swine industry, causing significant economic losses due to its impact on reproductive and respiratory health. Current treatments and vaccines have limited efficacy, necessitating the development of novel therapeutic strategies. This paper addresses the challenge of controlling PRRSV by exploring a nanotechnology-based approach that targets not only viral replication but also the host's detrimental responses, such as inflammation and ferroptosis, which exacerbate disease severity.

Methods

The researchers synthesized C3G-Cs-SeNPs through a self-assembly process. They then characterized these nanoparticles using various techniques including Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), X-ray Photoelectron Spectroscopy (XPS), X-ray Diffraction (XRD), and Dynamic Light Scattering (DLS) to assess their size, morphology, composition, and stability.

The antiviral activity was evaluated using cell-based assays on Marc-145 cells and porcine alveolar macrophages (rPAMs). Key methods included:

  • Cytotoxicity assays (CCK-8): To determine the safety of the nanoparticles.
  • Antioxidant assays (ABTS, DPPH, H2O2, OH radical scavenging): To measure the nanoparticles' ability to neutralize reactive oxygen species (ROS).
  • Viral assays:
    • Virus titration (TCID50): To quantify viral load.
  • Indirect Immunofluorescence Assay (IFA): To visualize viral protein expression.
  • Quantitative Real-Time PCR (qRT-PCR): To measure viral RNA replication and expression of host genes related to inflammation and ferroptosis.
  • Western Blotting: To assess protein levels of viral components, inflammatory cytokines, and key proteins involved in ferroptosis and antioxidant pathways.
  • ROS generation assay (DCFH-DA): To measure intracellular ROS levels.
  • Mitochondrial membrane potential assay (JC-1): To assess mitochondrial function.
  • Intracellular lipid peroxidation assay: To measure lipid peroxidation levels.
  • SIRT1 knockdown experiments: Using siRNA to investigate the role of the SIRT1 pathway.
  • Nrf2 inhibition experiments: Using the inhibitor ML385 to explore the role of the Nrf2 pathway.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Synergistic Antiviral Action: C3G-Cs-SeNPs exhibit a dual mechanism of action, simultaneously targeting viral replication and host-directed responses like inflammation and ferroptosis.
  • Modulation of Ferroptosis: PRRSV infection induces ferroptosis, a form of regulated cell death. C3G-Cs-SeNPs effectively mitigate this by restoring redox homeostasis and enhancing antioxidant enzyme activity.
  • Targeting Key Host Pathways: The nanoparticles appear to activate the SIRT1/Nrf2/HO-1 signaling pathway, which is crucial for regulating inflammation, oxidative stress, and ferroptosis. This suggests a host-directed antiviral strategy.
  • Improved Nanoparticle Properties: The self-assembly of C3G with chitosan-coated SeNPs results in nanoparticles with enhanced stability, biocompatibility, and reduced cytotoxicity compared to some other nanoparticle formulations.
  • Broad-Spectrum Potential: The study's findings suggest that C3G-Cs-SeNPs could be a promising therapeutic candidate not only for PRRSV but potentially for other respiratory viral infections.

Key Results

  • Nanoparticle Characterization: C3G-Cs-SeNPs were successfully synthesized as spherical particles with an average size of 180-240 nm and a zeta potential of -11 mV, demonstrating good stability.
  • Antioxidant Activity: C3G-Cs-SeNPs significantly scavenged ROS, ABTS, DPPH, H2O2, and hydroxyl radicals, indicating potent antioxidant properties.
  • Antiviral Efficacy: C3G-Cs-SeNPs significantly inhibited PRRSV replication, reducing viral titers (TCID50) and ORF7 mRNA expression in a dose-dependent manner. They also reduced PRRSV N protein expression.
  • Inflammation Reduction: Treatment with C3G-Cs-SeNPs significantly decreased the expression of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) in PRRSV-infected cells.
  • Ferroptosis Inhibition: C3G-Cs-SeNPs reduced markers of ferroptosis (e.g., COX-2, Keap1) and restored levels of protective proteins (e.g., GPX4, FTH1, SLC7A11). They also preserved mitochondrial membrane potential.
  • Pathway Activation: C3G-Cs-SeNPs treatment led to increased expression of SIRT1, Nrf2, and HO-1 at both mRNA and protein levels, suggesting activation of the SIRT1/Nrf2/HO-1 pathway.
  • SIRT1 and Nrf2 Knockdown Effects: Knockdown of SIRT1 or inhibition of Nrf2 reversed the protective effects of C3G-Cs-SeNPs, highlighting the critical role of this pathway.

Limitations and Future Work

  • In Vitro Models: The study primarily used in vitro models (Marc-145 cells and rPAMs). The authors acknowledge that these may not fully capture the complexity of PRRSV pathogenesis in vivo.
  • In Vivo Validation: Future work should validate these findings in porcine models to assess the efficacy, safety, and pharmacokinetics of C3G-Cs-SeNPs.
  • Long-Term Stability and Toxicity: Further investigation is needed to determine the long-term stability and potential toxicity of C3G-Cs-SeNPs in biological environments.
  • Selenium Accumulation and Off-Target Effects: The study suggests further investigation into selenium accumulation and potential off-target effects of C3G-Cs-SeNPs.
  • Molecular Interactions: The precise molecular interactions between C3G-Cs-SeNPs and cellular targets require further elucidation.
  • Host Immune Responses: The impact of these nanoparticles on host immune responses beyond inflammation and ferroptosis needs further investigation.
  • Broader Applications: The authors suggest exploring the efficacy of C3G-Cs-SeNPs against other respiratory viruses and chronic inflammatory diseases where redox imbalance and ferroptosis play a role.
  • Combination Therapies: Combining C3G-Cs-SeNPs with existing antiviral agents or immunomodulators could potentially improve therapeutic outcomes.

Summary updated

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) is a highly contagious pathogen that causes substantial economic losses in the global swine industry, primarily by impairing reproductive performance and respiratory health. However, current therapeutic approaches remain limited in effectively controlling PRRSV infection. Here, we present self-assembled cyanidin-3-O-glucoside (C3G)-based nanoparticles (C3G-Cs-SeNPs) as a promising antiviral agent against PRRSV infection. These nanoparticles demonstrated excellent stability and biocompatibility, with minimal cytotoxicity in Marc-145 cells. C3G-Cs-SeNPs significantly reduced ROS levels in PRRSV-infected cells, enhancing the antioxidant capacity and mitigating oxidative stress. In addition, they effectively inhibited key stages of the PRRSV lifecycle, including viral internalization and replication, leading to a marked decrease in viral proliferation. Moreover, C3G-Cs-SeNPs alleviated ferroptosis by restoring redox homeostasis through enhanced antioxidant enzyme activity. Mechanistically, these nanoparticles potentially activate the SIRT1/Nrf2/HO-1 signaling pathway, which plays a critical role in regulating inflammation and ferroptosis in PRRSV-infected cells. These findings suggest that C3G-Cs-SeNPs could serve as a novel therapeutic approach to modulate inflammation, ferroptosis, and viral replication in respiratory viral infections. Our study highlights the therapeutic potential of C3G-Cs-SeNPs in combating PRRSV infection, with important implications for viral infection management and respiratory disease treatment.IMPORTANCEPorcine reproductive and respiratory syndrome virus (PRRSV) remains a major challenge in the swine industry, causing significant economic losses due to its high mutation rate and ability to evade host immunity. Current antiviral treatments and vaccines offer limited efficacy, necessitating the development of novel therapeutic strategies. This study introduces self-assembled cyanidin-3-O-glucoside-based chitosan-selenium nanoparticles (C3G-Cs-SeNPs) as a promising antiviral agent. These nanoparticles effectively inhibit PRRSV replication, reduce oxidative stress, and alleviate inflammation and ferroptosis by activating the SIRT1/Nrf2/HO-1 signaling pathway. By mitigating virus-induced cellular damage, C3G-Cs-SeNPs offer a potential therapeutic approach for PRRSV and other respiratory viral infections. This study highlights the role of ferroptosis in PRRSV pathogenesis and presents an innovative nanotechnology-based solution to combat viral infections, contributing to the development of more effective antiviral strategies.
BibTeX
@article{chen2025self,
  author = {Xiaohan Chen and Yipeng Pang and Fructueux Modeste Amona and Zilu Liu and Fang Wang and Liang Yuan and Jiachen Yang and W. Zhang and Xingtang Fang and Xi Chen},
  title = {{Self-assembled cyanidin-3-O-glucoside nanoparticles alleviate inflammation and ferroptosis induced by PRRSV infection}},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.00954-25},
}
Figure